awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37407066-2C287789-2307-4AE9-BF0C-87919CC60536
Q37407066-2C287789-2307-4AE9-BF0C-87919CC60536
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37407066-2C287789-2307-4AE9-BF0C-87919CC60536
Phase II study of bevacizumab in combination with sorafenib in recurrent glioblastoma (N0776): a north central cancer treatment group trial.
P2860
Q37407066-2C287789-2307-4AE9-BF0C-87919CC60536
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37407066-2C287789-2307-4AE9-BF0C-87919CC60536
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f622789a0e355d6caac7691bded0b776bb1ef43b
P2860
Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.